Omalizumab
OMALIZUMAB
- CAS:
- 242138-07-4
- MF:
- MW:
- 0
Suppliers by country/region
Company Type
Properties
- form
- Solid
- color
- White to light yellow
Safety Information
Use
Omalizumab is a recombinant humanized construct of murine IgG1k monoclonal antibody introduced for the treatment of allergic asthma. It forms complexes with free, circulating serum IgE, which results in the inhibition of binding of IgE to the high-affinity IgE-receptor (FCeRI) on the surface of mast cells and basophils. Reduction in surface-bound IgE on FceRI-bearing cells limits the degree of release of mediators of the allergic response.
0 India supplier list of "OMALIZUMAB"
- Product Name:Omalizumab (anti-IgE)
- Products Intro:Purity: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I | Package: $49.9/100μg;$207.9/1mg;$627.9/5mg;$927.9/10mg;Bulk package | CustNote: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- Company Type: Trader
- Country/Region: UNITED STATES
- Main Products: Chemicals and BioChemicals,Materials Science,ligands acting on targets,Proteins,Antibodies
- Product Name:Omalizumab
- Products Intro:Brand:ACCEL | Product Number:XP2795 | Purity:97.00%
- Company Type: Trader
- Country/Region: UNITED STATES